Philip Hemme (@PhilipHemme) is the Co-Founder and CEO of GBR’s partner organisation Labiotech.eu. Recently, we had a chance to do a short Q&A with Philip to find out how Labiotech is helping to improve the European Biotech scene:

Q: Firstly, what is Labiotech and what inspired you to found it?

Philip: Labiotech.eu is Europe’s leading digital media for Biotech. We cover the industry extensively with over 20 news stories per week and we have over 40,000 visitors monthly. My partner Joachim and I started this venture out of a personal frustration. We were studying Biotech but couldn’t find a modern, high quality and free source of information for Biotech. So we decided to launch our own and hoped that many other people needed it too. We are now starting to show Labiotech.eu makes sense and our goal is to be the TechCrunch for Biotech.

Philip Hemme and his Labiotech.eu co-founder Joachim Eeckhout

Q: Tell us a bit about the upcoming Labiotech Refresh and what makes it special as a biotech conference?

Philip: Labiotech Refresh is the first event we’re organising, taking place on May 24th in Berlin. We want it to be Europe’s most refreshing Biotech event taking inspiration from more startup-style events and from events in the US. We have gathered a fantastic line of speakers (CureVac, Seventure, Medigene), great sponsors (Bayer, Merck) and are awaiting 150 leaders to attend. We believe there is a need in Europe for new types of Biotech events, as you are doing with the GapSummit, and I would love to see members of the GBR community in May in Berlin.

P.S. our early bird prices stop on Friday the 15th 2016 

Categories: Blog

Tags: GapSummit 2016, Public perception, Biotechnology, Start up

Comments closed for this post.